Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1
Besse, B., Felip, E., Garcia Campelo, R., Cobo, M., Mascaux, C., Madroszyk, A., Cappuzzo, F., Hilgers, W., Romano, G., Denis, F., Viteri, S., Debieuvre, D., Galetta, D., Baldini, E., Razaq, M., Robinet, G., Maio, M., Delmonte, A., Roch, B., Masson, P., Schuette, W., Zer, A., Remon, J., Costantini, D., Vasseur, B., Dziadziuszko, R., Giaccone, G., Zemanová, M., Besse, B., Bonnet, C., Cadranel, J., Chouaid, C., Cortot, A., Debieuvre, D., Delclaux, B., Denis, F., Duchemann, B., El Kouri, C., Ferrand, F.R., Ginoux, M., Hilgers, W., Madroszyk, A., Masson, P., Mazieres, J., Molinier, O., Moro-Sibilot, D., Pichon, E., Mascaux, C., Robinet, G., Roch, B., Zalcman, G., Schmidtke-Schrezenmeier, G., Schuette, W., Urban, L., Gottfried, M., Nechushtan, H., Peled, N., Wollner, M., Zer, A., Baldini, E., Bonanno, L., Bonetti, A., Cappuzzo, F., Delmonte, A., Galetta, D., Maio, M., Minotti, V., Rea, A., Romano, G., Tassinari, D., Tonini, G., Dziadziuszko, R., Karaszewska, B., Szczęsna, A., Cobo, M., De Castro, J., Felip, E., Garcia Campelo, M.R., Hernández, A., Moran, T., Provencio, M., Viteri, S., Dasgupta, A., Gabrail, N., Giaccone, G., Harshad, A., Liu, S., Oubre, D., Panikkar, R., Razaq, M., Sanborn, R.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
Palbociclib-induced senescence upregulates the expression of IL-8 and may enhance the response to inmunotherapy
Martinez Bueno, A., Bertran Aramillo, J., Garcia Mosquera, J.J., Gimenez Capitan, A., Codony-Servat, J., Aguilar, A., Garcia Román, S., Mayo de las Casas, C., Viteri, S., Molina, M.A.
Published in Annals of oncology (01.05.2019)
Published in Annals of oncology (01.05.2019)
Get full text
Journal Article
An open-label, randomized, phase I/II trial of IO102 and pembrolizumab, or IO102, pembrolizumab and chemotherapy, as first-line treatment for patients with metastatic non-small cell lung cancer
Spicer, J., Provencio, M., Garrido Lopez, P., Bosch-Barrera, J., de Castro Carpeño, F.J., Felip, E., Trigo, J., Viteri, S., Coart, E., Schmidt, E., Christiansen, A.V., Zocca, M.-B., Andersen, M.H., Ehrnrooth, E., Paz-Ares, L.
Published in Annals of oncology (01.04.2019)
Published in Annals of oncology (01.04.2019)
Get full text
Journal Article
Combination of the S49076 with gefitinib in NSCLC patients progressing on EGFR-TKI and harboring MET/AXL dysregulation
Viteri, S., Chang, G.-C., Chiari, R., Cho, B.C., Ciardiello, F., Curigliano, G., Hida, T., Lee, D.H., Lim, W.T.D., Lin, C.-C., Martinez, A., Murakami, H., Natsume, I., Nishio, M., Paz-Ares, L., Soo, R.A., Cattan, V., Gandossi, E., Heck, H., Park, K.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Homology-directed repair (HDR)-defective lung adenocarcinomas (LUACs) in circulating tumor DNA (ctDNA)
Karachaliou, N., Lefterova, M., Draper, J.F., Molina, M.-A., Chaib, I., Palmero, R., Taus, A., Viteri, S., González Cao, M., Majem Tarruella, M., Carcereny Costa, E., Moran, T., Garde Noguera, J., Felip Font, E., Olsen, S., Jackson, M., Sampayo, M., Faull, I., Dix, D., Rosell, R.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
3120 Analysis of gene expression in the re-replication pathway and selective blockade with checkpoint inhibitors as a therapeutic option in NSCLC
Morales-Espinosa, D, Molina-Vila, M.A, Giménez-Capitán, A, García-Román, S, Bertrán-Alamillo, J, Méndez-Romero, P, Ramírez-Serrano, J.L, Viteri, S, Karachaliou, N, Rosell, R
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
3101 Updated efficacy and safety results from a global phase 2, open-label, single-arm study (NP28673) of alectinib in crizotinib-refractory ALK+ non-small-cell lung cancer (NSCLC)
Barlesi, F, Dingemans, A.M.C, Ou, I, Ahn, J.S, Petris, L.D, Kim, D.W, Yang, J.C.H, Hughes, B, Lena, H, Moro-Sibilot, D, Bearz, A, Viteri, S, Mekhail, T, Spira, A, Zeaiter, A, Bordogna, W, Sturm, C, Golding, S, Morcos, P.N, Govindan, R
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
254 Molecular analysis in breast cancer: correlation with Immunohistochemical classification and pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC)
Baulies, S, Gonzalez-Cao, M, Karachaliou, N, Capitan, A. Rodriguez, Molina-Vila, M.A, Cusido, M.T, Teixido, C, Viteri, S, Fabregas, R, Gonzalez, X, Rosell, R
Published in European journal of cancer (1990) (01.11.2014)
Published in European journal of cancer (1990) (01.11.2014)
Get full text
Journal Article
514 Hypoxia inducible factor (HIF)-1a expression levels and p53 mutations are prognostic factors for survival in breast cancer patients treated with neoadjuvant chemotherapy
Molina-Vila, M, Baulies, S, Gonzalez-Cao, M, Karachaliou, N, Capitan, A. Rodriguez, Viteri, S, Cusido, M, Fabregas, R, Teixido, C, Rosell, R
Published in European journal of cancer (1990) (01.11.2014)
Published in European journal of cancer (1990) (01.11.2014)
Get full text
Journal Article
Immunotherapy, cancer and PET
Simó-Perdigó, M, Vercher-Conejero, J L, Viteri, S, García-Velloso, M J
Published in Revista Española de medicina nuclear e imagen molecular (English ed.) (01.03.2021)
Published in Revista Española de medicina nuclear e imagen molecular (English ed.) (01.03.2021)
Get full text
Journal Article
Preliminary Results of the Combination of Bevacizumab and Weekly Paclitaxel in Advanced Melanoma
González-Cao, M., Viteri, S., Díaz-Lagares, A., González, A., Redondo, P., Nieto, Y., Espinós, J., Chopitea, A., Ponz, M., Martín-Algarra, S.
Published in Oncology (01.01.2008)
Published in Oncology (01.01.2008)
Get full text
Journal Article
Large scale, prospective screening of EGFR mutations in the blood of advanced NSCLC patients to guide treatment decisions
Mayo-de-las-Casas, C., Jordana-Ariza, N., Garzón-Ibañez, M., Balada-Bel, A., Bertrán-Alamillo, J., Viteri-Ramírez, S., Reguart, N., Muñoz-Quintana, M.A., Lianes-Barragan, P., Camps, C., Jantús, E., Remon-Massip, J., Calabuig, S., Aguiar, D., Gil, M.L., Viñolas, N., Santos-Rodríguez, A.K., Majem, M., García-Peláez, B., Villatoro, S., Pérez-Rosado, A., Monasterio, J.C., Ovalle, E., Catalán, M.J., Campos, R., Morales-Espinosa, D., Martínez-Bueno, A., González-Cao, M., González, X., Moya-Horno, I., Sosa, A.E., Karachaliou, N., Rosell, R., Molina-Vila, M.A.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
The EPICAL trial, a phase Ib study combining first line afatinib with anti-EGF vaccination in EGFR-mutant metastatic NSCLC
Rodríguez-Abreu, D., Cobo, M., García-Román, S., Viteri-Ramírez, S., Jordana-Ariza, N., García-Peláez, B., Reguart, N., Aguilar, A., Codony-Servat, J., Drozdowskyj, A., Molina-Vila, M.A., d'Hondt, E., Rosell, R.
Published in Lung cancer (Amsterdam, Netherlands) (01.02.2022)
Published in Lung cancer (Amsterdam, Netherlands) (01.02.2022)
Get full text
Journal Article
Response of resistant melanoma to a combination of weekly paclitaxel and bevacizumab
González Cao, M, Viteri, S, Garrán, C, Nieto, Y, Aristu, J, Ponz, M, Martín Algarra, S
Published in Clinical & translational oncology (01.02.2007)
Published in Clinical & translational oncology (01.02.2007)
Get full text
Journal Article
50 Genetic aberrations as determinants of response to chemotherapy
Rosell, R, Massuti, B, Isla, D, Camps, C, Moran, T, Carcereny, E, Viteri, S, Molina, M.A, Taron, M, Cardona, A.F
Published in European journal of cancer supplements (2009)
Published in European journal of cancer supplements (2009)
Get full text
Journal Article
19P Stable disease (SD) on amivantamab in post-platinum epidermal growth factor receptor (EGFR) exon 20 insertion (Exon20ins) mutated non-small cell lung cancer (NSCLC): A response-based analysis
Girard, N., Park, K., Viteri, S., Schioppa, C.A., Diels, J., Oguz, M., Rodrigues, B.H., Rahhali, N., Sermon, J., Ghilotti, F., Li, T., Knoblauch, R.E., Mahadevia, P., Cho, B.C.
Published in Annals of oncology (01.04.2022)
Published in Annals of oncology (01.04.2022)
Get full text
Journal Article
1380P Treatment (Tx) sequencing with tepotinib in previously treated patients (pts) with MET exon 14 (METex14) skipping NSCLC in the VISION trial
Viteri, S., Felip, E., Griesinger, F., Garassino, M.C., Sakai, H., Le, X., Veillon, R., Smit, E.F., Raskin, J., Thomas, M., Ahn, M-J., Vlassak, S., Bruns, R., Johne, A., Paik, P.K.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
P08.04 Comparative Clinical Outcomes Between EGFR Exon20ins and Wildtype NSCLC Treated with Immune Checkpoint Inhibitors
Bazhenova, L., Girard, N., Minchom, A., Ou, S., Gadgeel, S., Trigo, J.M., Viteri, S., Londhe, A., Mahadevia, P., Bauml, J.
Published in Journal of thoracic oncology (01.10.2021)
Published in Journal of thoracic oncology (01.10.2021)
Get full text
Journal Article
EP08.02-081 Cabozantinib Plus Atezolizumab in First or Second-Line Advanced NSCLC and Previously-Treated EGFR Mutant Advanced NSCLC
Neal, J.W., Lim, F.L., Aix, S.P., Viteri, S., Santoro, A., Spencer, K., Fang, B., Khrizman, P., Kim, J., Subbiah, V., Sudhagoni, R., Samaraweera, L., Andrianova, L., Felip, E.
Published in Journal of thoracic oncology (01.09.2022)
Published in Journal of thoracic oncology (01.09.2022)
Get full text
Journal Article
OA21.06 ctDNA Dynamics, Prognostic Markers and Resistance Mechanisms in Tepotinib-Treated METex14 Skipping NSCLC in the VISION Trial
Le, X., Garassino, M.C., Ahn, M.-J., Felip, E., Cortot, A.B., Sakai, H., Mazieres, J., Thomas, M., Viteri, S., Conte, P., Yang, J.C.-H., Iams, W.T., Griesinger, F., Stroh, C., Juraeva, D., Wang, D., Johne, A., Paik, P.K.
Published in Journal of thoracic oncology (01.11.2023)
Published in Journal of thoracic oncology (01.11.2023)
Get full text
Journal Article